The energy giant said it expects the charge in the fourth quarter due to payments for emission certificates, and also anticipates results in its integrated gas division to be significantly lower than ...

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the twelfth annual Drugs to Watch™ report, a trusted guide to the therapies poised to ...

A mixture of macro fears for inflation and concerns about what the next Trump presidency may hold are dominating markets as we move to the middle of the week. The sell off in stocks in the US was ...

Novo Nordisk shares fell 30% in the fourth quarter on disappointing clinical trial data, concerns about its experimental ...

European stock futures broadly edged lower with U.S. inflation worries back on the forefront. U.S. stocks fell sharply and bond yields spiked Tuesday after the latest services industry and job ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

It’s not at all clear what a tariff would mean for Novo, which manufactures its medicines in facilities all over the world, ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The millennial-focused digital health company Hims & Hers (HIMS) has donated $1 million to President-elect Donald Trump’s ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 478.78% and ...

Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease across diverse populatio | ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.